BioCentury
ARTICLE | Company News

Cerulean, Novartis deal

October 24, 2016 7:00 AM UTC

Cerulean partnered with Novartis to develop nanoparticle-drug conjugates (NDCs) using Cerulean’s Dynamic Tumor Targeting platform with undisclosed Novartis compounds against up to five targets. The pl...